Raptor Pharmaceutical Corp Company Profile (NASDAQ:RPTP)

About Raptor Pharmaceutical Corp

Raptor Pharmaceutical Corp logoRaptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RPTP
  • CUSIP: 75382F10
Key Metrics:
  • Previous Close: $9.00
  • 50 Day Moving Average: $8.81
  • 200 Day Moving Average: $6.51
  • 52-Week Range: $2.94 - $9.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -20.45
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 1.18
Profitability:
  • Net Margins: -79.29%
  • Return on Equity: -66.67%
  • Return on Assets: -17.89%
Debt:
  • Debt-to-Equity Ratio: 1.33%
  • Current Ratio: 3.57%
  • Quick Ratio: 3.30%
Additional Links:
Companies Related to Raptor Pharmaceutical Corp:

Analyst Ratings

Consensus Ratings for Raptor Pharmaceutical Corp (NASDAQ:RPTP) (?)
Ratings Breakdown: 6 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $8.40 (6.67% downside)

Analysts' Ratings History for Raptor Pharmaceutical Corp (NASDAQ:RPTP)
Show:
DateFirmActionRatingPrice TargetDetails
9/16/2016Cowen and CompanyDowngradeOutperform -> Market Perform$9.00View Rating Details
9/12/2016WedbushReiterated RatingNeutral$9.00 -> $4.00View Rating Details
9/8/2016FBR & CoReiterated RatingHoldView Rating Details
8/8/2016Citigroup Inc.DowngradeBuy -> Neutral$6.00 -> $8.00View Rating Details
4/12/2016Leerink SwannReiterated RatingOutperform$11.00View Rating Details
4/11/2016Oppenheimer Holdings, Inc.Reiterated RatingMarket PerformView Rating Details
3/20/2016JMP SecuritiesDowngradeHoldView Rating Details
8/22/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Raptor Pharmaceutical Corp (NASDAQ:RPTP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.18)($0.16)$28.52 million$32.05 millionViewListenView Earnings Details
5/5/2016Q116($0.17)($0.17)$27.17 million$27.47 millionViewN/AView Earnings Details
2/25/2016Q415($0.19)($0.17)$26.08 million$24.67 millionViewListenView Earnings Details
11/5/2015Q315($0.18)($0.18)$24.25 million$25.80 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.12)$21.40 million$23.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.25)($0.24)$19.10 million$20.50 millionViewN/AView Earnings Details
2/26/2015Q414($0.14)($0.25)$20.12 million$17.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.18)($0.04)$18.90 million$23.80 millionViewN/AView Earnings Details
8/7/2014Q214($0.19)($0.15)$14.58 million$16.31 millionViewN/AView Earnings Details
5/8/2014Q413($0.17)($0.20)$11.81 million$12.10 millionViewN/AView Earnings Details
3/13/2014Q313($0.18)($0.19)$10.20 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.30)($0.30)ViewN/AView Earnings Details
3/14/2013Q1 2013($0.27)($0.37)ViewN/AView Earnings Details
1/9/2013Q1 2013($0.23)($0.26)$0.25 millionViewN/AView Earnings Details
11/14/2012Q412($0.20)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Raptor Pharmaceutical Corp (NASDAQ:RPTP)
Current Year EPS Consensus Estimate: $-0.89 EPS
Next Year EPS Consensus Estimate: $-0.44 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.17)($0.15)($0.16)
Q2 20163($0.15)($0.14)($0.15)
Q3 20163($0.21)($0.15)($0.17)
Q4 20164($0.21)($0.14)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Raptor Pharmaceutical Corp (NASDAQ:RPTP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Raptor Pharmaceutical Corp (NASDAQ:RPTP)
Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 54.88%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2015Suzanne Louise BruhnDirectorSell18,258$12.47$227,677.26View SEC Filing  
9/2/2015Raymond AndersonDirectorSell4,916$12.51$61,499.16View SEC Filing  
8/31/2015Raymond AndersonDirectorSell8,084$12.52$101,211.68View SEC Filing  
7/1/2015Llew KeltnerDirectorSell50,000$16.05$802,500.00View SEC Filing  
6/18/2015Thomas E DaleyInsiderSell35,000$15.00$525,000.00View SEC Filing  
6/10/2015Suzanne Louise BruhnDirectorSell30,000$13.45$403,500.00View SEC Filing  
5/4/2015Richard L FranklinDirectorSell10,000$9.61$96,100.00View SEC Filing  
4/2/2015Richard L FranklinDirectorSell10,000$10.37$103,700.00View SEC Filing  
3/23/2015Christopher M StarrDirectorSell20,033$11.62$232,783.46View SEC Filing  
3/2/2015Richard L FranklinDirectorSell10,000$9.18$91,800.00View SEC Filing  
2/24/2015Christopher M StarrDirectorSell30,000$9.52$285,600.00View SEC Filing  
2/2/2015Richard L FranklinDirectorSell7,109$9.20$65,402.80View SEC Filing  
1/22/2015Christopher M StarrDirectorSell30,000$9.45$283,500.00View SEC Filing  
1/15/2015Christopher M StarrDirectorSell30,000$9.73$291,900.00View SEC Filing  
1/12/2015Raymond AndersonDirectorSell10,000$10.58$105,800.00View SEC Filing  
12/22/2014Christopher M StarrCEOSell30,000$9.00$270,000.00View SEC Filing  
12/15/2014Christopher M StarrCEOSell30,000$8.15$244,500.00View SEC Filing  
11/24/2014Christopher M StarrCEOSell30,000$9.97$299,100.00View SEC Filing  
10/22/2014Christopher M StarrCEOSell30,000$10.25$307,500.00View SEC Filing  
9/23/2014Christopher M StarrCEOSell30,000$10.21$306,300.00View SEC Filing  
9/16/2014Christopher M StarrCEOSell32,896$10.60$348,697.60View SEC Filing  
9/10/2014Raymond AndersonDirectorSell10,000$10.81$108,100.00View SEC Filing  
8/25/2014Erich SagerDirectorSell10,000$11.01$110,100.00View SEC Filing  
7/7/2014Llew KeltnerDirectorSell10,000$11.21$112,100.00View SEC Filing  
5/13/2014Georgia ErbezCFOBuy16,100$7.90$127,190.00View SEC Filing  
4/7/2014Vijay SamantDirectorSell5,000$8.59$42,950.00View SEC Filing  
3/17/2014Christopher StarrCEOSell19,316$10.79$208,419.64View SEC Filing  
1/13/2014Timothy WalbertDirectorSell5,520$15.06$83,131.20View SEC Filing  
1/9/2014Thomas DaleyInsiderSell15,000$14.17$212,550.00View SEC Filing  
1/7/2014Llew KeltnerDirectorSell10,000$13.25$132,500.00View SEC Filing  
1/2/2014Richard FranklinDirectorSell10,715$13.12$140,580.80View SEC Filing  
12/9/2013Vijay SamantDirectorSell5,000$13.86$69,300.00View SEC Filing  
11/13/2013Timothy WalbertDirectorSell5,521$12.44$68,681.24View SEC Filing  
11/4/2013Richard FranklinDirectorSell10,715$14.88$159,439.20View SEC Filing  
10/15/2013Christopher M StarrCEOSell25,000$13.77$344,250.00View SEC Filing  
10/14/2013Suzanne Louise BruhnDirectorSell2,760$13.58$37,480.80View SEC Filing  
10/7/2013Vijay SamantDirectorSell5,000$14.76$73,800.00View SEC Filing  
9/16/2013Christopher StarrCEOSell25,000$14.21$355,250.00View SEC Filing  
9/16/2013Erich SagerDirectorSell17,000$14.21$241,570.00View SEC Filing  
9/13/2013Suzanne Louise BruhnDirectorSell2,760$14.07$38,833.20View SEC Filing  
9/9/2013Richard L FranklinDirectorSell10,715$14.24$152,581.60View SEC Filing  
9/9/2013Thomas E DaleyInsiderSell25,000$14.28$357,000.00View SEC Filing  
8/30/2013Georgia ErbezCFOSell7,400$13.42$99,308.00View SEC Filing  
12/28/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
11/26/2012Erich SagerDirectorSell11,279$5.00$56,395.00View SEC Filing  
9/12/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Raptor Pharmaceutical Corp (NASDAQ:RPTP)
DateHeadline
News IconRaptor Pharmaceutical Corp RPTP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:RPTP)
www.bioportfolio.com - February 3 at 11:39 PM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - Aiken Advocate (NASDAQ:RPTP)
aikenadvocate.com - January 24 at 8:03 AM
News IconStock Tracker: Earnings & Estimates for Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - Aiken Advocate (NASDAQ:RPTP)
aikenadvocate.com - January 16 at 1:40 PM
News IconHome Business Raptor Pharmaceutical Corp. (NASDAQ: RPTP) Buy Rating Reiterated at Cowen and Company - BNB Daily (blog) (NASDAQ:RPTP)
www.baseball-news-blog.com - December 31 at 12:56 AM
News IconRaptor Pharmaceutical Corp. (NASDAQ: RPTP) stock reaches new 52-week high - BNB Daily (blog) (NASDAQ:RPTP)
www.baseball-news-blog.com - December 29 at 12:27 AM
News IconAerie completes enrollment of phase III trial for intraocular pressure eye drops (NASDAQ:RPTP)
www.massdevice.com - December 8 at 8:03 PM
News IconLysosomal Storage Diseases Therapeutics Market to Rise US$ 14.36 Bn by 2026 (NASDAQ:RPTP)
www.medgadget.com - December 8 at 8:03 PM
News IconHorizon tanks on Phase 3 failure (NASDAQ:RPTP)
www.biopharmadive.com - December 8 at 8:03 PM
News IconHorizon Pharma folds its cards on Friedreich’s Ataxia after Actimmune flunks PhIII (NASDAQ:RPTP)
endpts.com - December 8 at 8:03 PM
insidermonkey.com logoShould You Avoid MTS Systems Corporation (MTSC)? - Insider Monkey (blog) (NASDAQ:RPTP)
www.insidermonkey.com - December 8 at 8:46 AM
insidermonkey.com logoHere is What Hedge Funds Think About Tailored Brands Inc (TLRD) - Insider Monkey (blog) (NASDAQ:RPTP)
www.insidermonkey.com - December 6 at 7:16 PM
News IconRaptor Pharmaceutical Corp. (NASDAQ:RPTP) Under Analyst ... - UK Market News (NASDAQ:RPTP)
www.ukmarketnews.co.uk - December 2 at 7:12 PM
News IconNew Analyst Ratings On Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - NewsDen (NASDAQ:RPTP)
newsden.net - November 30 at 12:41 PM
News IconEarnings Take Center Stage; Analysts Weighing in on Raptor ... - CSZ News (NASDAQ:RPTP)
cincysportszone.com - November 21 at 7:44 PM
News IconRaptor Pharmaceutical Corp. RPTP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:RPTP)
www.bioportfolio.com - November 16 at 7:32 PM
News IconBroker Review: Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - UK ... - UK Market News (NASDAQ:RPTP)
www.ukmarketnews.co.uk - November 13 at 11:08 AM
finance.yahoo.com logoHORIZON PHARMACEUTICAL LLC Financials (NASDAQ:RPTP)
finance.yahoo.com - November 8 at 7:02 PM
biz.yahoo.com logoRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Art (NASDAQ:RPTP)
biz.yahoo.com - October 31 at 7:29 AM
News IconHorizon Pharma (HZNP) Stock: Spikes On Raptor Acquisition, Fortifies Pipeline and Raises FY 2016 Guidance (NASDAQ:RPTP)
cnafinance.com - October 26 at 10:37 AM
streetinsider.com logoHorizon Pharma (HZNP) Announces Completion of Raptor Pharma (RPTP) Acquisition (NASDAQ:RPTP)
www.streetinsider.com - October 26 at 10:37 AM
investingnews.com logoHorizon Pharma Completes Acquisition of Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
investingnews.com - October 25 at 7:08 PM
biz.yahoo.com logoRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisit (NASDAQ:RPTP)
biz.yahoo.com - October 25 at 7:08 PM
streetinsider.com logoHorizon Pharma (HZNP) Announces Completion of Raptor Pharma (RPTP) Acquisition - StreetInsider.com (NASDAQ:RPTP)
www.streetinsider.com - October 25 at 12:18 PM
marketwatch.com logoHow These Biotech Stocks are Faring? -- Raptor Pharma, Amicus Therapeutics, Neuralstem, and Macrocure (NASDAQ:RPTP)
www.marketwatch.com - October 21 at 7:10 PM
News IconInvestor News: Lawsuit filed against the Buyout of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) (NASDAQ:RPTP)
www.groundreport.com - October 20 at 7:24 PM
News IconInvestor News: Lawsuit filed against the Buyout of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - GroundReport (NASDAQ:RPTP)
www.groundreport.com - October 20 at 8:37 AM
biz.yahoo.com logoRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:RPTP)
biz.yahoo.com - October 20 at 8:37 AM
istreetwire.com logoStocks in the Spotlight: Raptor Pharmaceuticals Corp. (RPTP), Murphy Oil Corporation (MUR), Cobalt International ... - iStreetWire (NASDAQ:RPTP)
istreetwire.com - October 17 at 6:59 PM
News IconSell-side is Weighing in on Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Earnings - CSZ News (NASDAQ:RPTP)
cincysportszone.com - October 17 at 6:59 PM
stocksdaily.net logoRaptor Pharmaceutical Corp. (NASDAQ:RPTP) EPS Target At ... - Stocks Daily (NASDAQ:RPTP)
www.stocksdaily.net - October 16 at 6:52 PM
4-traders.com logoLawsuit Filed for Investors in Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Against the Takeover (NASDAQ:RPTP)
www.4-traders.com - October 14 at 6:51 PM
marketexclusive.com logoRaptor Pharmaceutical Corp. (NASDAQ:RPTP) Files An 8-K - Market Exclusive (NASDAQ:RPTP)
marketexclusive.com - October 12 at 7:01 PM
biz.yahoo.com logoRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material (NASDAQ:RPTP)
biz.yahoo.com - October 11 at 7:28 PM
feeds.reuters.com logoBRIEF-Raptor Pharmaceutical Corp enters note redemption agreement (NASDAQ:RPTP)
feeds.reuters.com - October 11 at 5:46 PM
finance.yahoo.com logoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Raptor Pharmaceutical Corp. (RPTP) (NASDAQ:RPTP)
finance.yahoo.com - October 6 at 6:50 PM
News IconKeep an eye on Active stock of Yesterday- Raptor Pharmaceuticals Corp.'s (RPTP) - Hot Stocks Point (NASDAQ:RPTP)
www.hotstockspoint.com - September 29 at 12:26 PM
News IconRetaining Analysts Views in Focus: Raptor Pharmaceuticals Corp ... - Street Wise Report (press release) (blog) (NASDAQ:RPTP)
streetwisereport.com - September 28 at 6:52 PM
News IconRaptor Pharmaceutical Corp. (NASDAQ:RPTP) Quarterly Analytical Analysis - Newburgh Press (NASDAQ:RPTP)
newburghpress.com - September 28 at 6:52 PM
seekingalpha.com logoHorizon Pharma: Another Core Plus Biotech Worth Buying (NASDAQ:RPTP)
seekingalpha.com - September 28 at 12:19 PM
News IconInvestor News: Buyout of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) under Investigation (NASDAQ:RPTP)
www.groundreport.com - September 28 at 12:19 PM

Social

What is Raptor Pharmaceutical Corp's stock symbol?

Raptor Pharmaceutical Corp trades on the NASDAQ under the ticker symbol "RPTP."

Where is Raptor Pharmaceutical Corp's stock going? Where will Raptor Pharmaceutical Corp's stock price be in 2017?

7 equities research analysts have issued 12 month price targets for Raptor Pharmaceutical Corp's stock. Their predictions range from $4.00 to $11.00. On average, they expect Raptor Pharmaceutical Corp's share price to reach $8.40 in the next twelve months.

When will Raptor Pharmaceutical Corp announce their earnings?

Raptor Pharmaceutical Corp is scheduled to release their next quarterly earnings announcement on Thursday, November, 3rd 2016.

Who owns Raptor Pharmaceutical Corp stock?

Raptor Pharmaceutical Corp's stock is owned by many different of retail and institutional investors. Top institutional investors include Credit Suisse Trust Limited in its capacity as trustee of The Mandalay Trust (5.13%). Company insiders that own Raptor Pharmaceutical Corp stock include Christopher M Starr, Llew Keltner, Raymond Anderson, Richard L Franklin, Suzanne Louise Bruhn and Thomas E Daley.

How do I buy Raptor Pharmaceutical Corp stock?

Shares of Raptor Pharmaceutical Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Raptor Pharmaceutical Corp stock cost?

One share of Raptor Pharmaceutical Corp stock can currently be purchased for approximately $9.00.

Raptor Pharmaceutical Corp (NASDAQ:RPTP) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Raptor Pharmaceutical Corp (NASDAQ:RPTP)

Earnings History Chart

Earnings by Quarter for Raptor Pharmaceutical Corp (NASDAQ:RPTP)

Dividend History Chart

Dividend Payments by Quarter for Raptor Pharmaceutical Corp (NASDAQ:RPTP)

Last Updated on 2/21/2017 by MarketBeat.com Staff